Our findings thus identify the ITGA5-DSC2 axis as a key mechanism behind Empagliflozin’s cardioprotective action in sepsis, offering a novel explanation for this drug’s remarkable properties and opening a new avenue for treating this condition. The gene discussed is DSC2; the disease is Sepsis.